Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Net sales (Note 2) $ 5,130 $ 5,949 $ 13,098 $ 15,430
Cost of sales (Note 2) 1,620 2,132 4,816 5,346
Gross profit 3,510 3,817 8,282 10,084
Operating expenses:        
Sales and marketing 875 1,091 4,724 5,163
Administration 1,917 1,306 6,228 4,521
Research and development 356 181 907 586
Impairment charge 3,577 0 3,577 0
Total operating expense 6,725 2,578 15,436 10,270
Income (loss) from operations (3,215) 1,239 (7,154) (186)
Interest income 1 0 3 2
Interest expense (2) (3) (7) (9)
Income (loss) before income tax (3,216) 1,236 (7,158) (193)
Income tax (Note 5) 0 0 0 0
Net income (loss) $ (3,216) $ 1,236 $ (7,158) $ (193)
Basic income (loss) per share:        
Net income (loss) (in dollors per share) $ (0.18) $ 0.08 $ (0.42) $ (0.01)
Diluted income (loss) per share:        
Net income (loss) (in dollors per share) $ (0.18) $ 0.08 $ (0.42) $ (0.01)
Weighted average common shares outstanding:        
Basic (in shares) 18,208 15,860 17,216 15,819
Diluted (in shares) 18,208 16,307 17,216 15,819